Diabetic Retinopathy Market Analysis and Growth Forecast by Regions and Applications to 2025
The Diabetic Retinopathy Market report provides a detailed evaluation of the industry by highlighting information on different aspects which include drivers, restraints, growth opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. It also provides a detailed analysis of global market size, regional and country-level market size, competitive landscape, impact of domestic market players and value chain optimization. Furthermore, it sheds light on the market contribution, recent developments and successful marketing strategies of leading companies.
Market Insights
The global Diabetic Retinopathy Market size is likely to reach USD 10.08 billion by 2025. Diabetes is a chronic disorder related with defects in the secretion of insulin from the hyperglycemia or pancreas associated to insulin resistance which eventually leads to long term multi-organ problems of kidneys, eye, blood vessels, nerves and heart.
Request a Sample Copy
of Diabetic Retinopathy Market Report @ https://www.millioninsights.com/industry-reports/diabetic-retinopathy-market/request-sample
Factors, such as
increasing aged population, up-gradation of healthcare infrastructure, rising
demand for initial detection systems, technological advancements, uncontrolled
glucose levels and ignorance towards treatment, and increasing research
activities towards developing advanced products are likely to drive the
diabetic retinopathy industry in the forthcoming period.
On the other hand, lack
of skilled professionals, presence of low-income groups, high cost associated
with the treatment and poor availability to healthcare services are anticipated
to hinder diabetic retinopathy market growth in future. However, prolonged
undiagnosed diabetes is likely to create lucrative opportunities for the
market. Diabetic retinopathy industry is anticipated to expand at a CAGR of
6.3% in the upcoming period as the scope, product types and its applications
are increasing across the globe.
Diabetic Retinopathy Management Outlook (Revenue, USD Million, 2014 -
2025)
• Anti-VEGF
• Intraocular steroid injection
• Laser surgery
• Vitrectomy
Key Players Analysis covered in these report
• Alimera Science
• Abbott Laboratories
• Allergan
• Bayer
• Novartis International
• Pfizer
• Boehringer Ingelheim GmbH
• Valeant Pharmaceutical and many others
Access Diabetic
Retinopathy Market Report with TOC @ https://www.millioninsights.com/industry-reports/diabetic-retinopathy-market
North America is a leading region in the
market. It is likely to maintain a dominance in the forecast period owing to
factors, such as a large number of aged populations, increase in occurrence of
diabetic retinopathy patients in the region, increasing healthcare
infrastructure and rising health awareness among population. In addition, North
America is followed by Asia-Pacific region owing to changing lifestyle of
people in the region, surge in diabetic population, increase in funding and
support provided by the government.
Comments
Post a Comment